Security Snapshot

Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) Institutional Ownership

CUSIP: 359664109

13F Institutional Holders and Ownership History from Q3 2016 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

86

Shares (Excl. Options)

8.26MFull value: 8,256,947 · shares · 30 Sep 2026

Price

$22.02

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-349,339
Value change
-$6,046,185
Number of holders
86
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
27,503,221
SEC-reported price per share
$20.82
Insider filing price
$20.82
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • FLGT - Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 359664109.
  • 86 institutions reported positions in Q3 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 140 to 86 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $321.83MFull value: $321,831,694 · USD · 30 Jun 2026
    to
    $181.82MFull value: $181,820,594 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 86 institutions filings for Q3 2026.

Open SEC evidence

Security key

359664109

13F reference period

Q3 2026

13F holders

86

13D/G owners

4

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
FLGT
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Hsieh Ming 32% +4.9% $138,411,608 +$81,682 8,872,539 +0.06% Ming Hsieh 22 May 2026
BARCLAYS PLC 7.6% +43% $42,396,117 +$12,335,507 2,338,451 +41% Barclays PLC 31 Mar 2025
BlackRock, Inc. 5.9% $32,993,391 1,819,823 BlackRock, Inc. 31 Mar 2025
MILLENNIUM MANAGEMENT LLC 3% -43% $24,677,381 -$19,766,494 939,375 -44% Millennium Management LLC 31 Dec 2025
As of 30 Sep 2026, 86 institutional investors reported holding
8.26MFull value: 8,256,947 · shares · 30 Sep 2026
shares of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT). This represents 30% of the company’s total
27.5MFull value: 27,503,221 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
24%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Diametric Capital, LP 3.4% 932,410 1.8% $20,531,668
TWO SIGMA INVESTMENTS, LP 3.4% 929,450 0.01% $20,466,489
VANGUARD CAPITAL MANAGEMENT LLC 2.8% 765,873 0% $16,864,523
DIMENSIONAL FUND ADVISORS LP 2.4% 646,625 0% $14,238,857
STATE STREET CORP 1.9% 516,943 0% $11,383,085
GEODE CAPITAL MANAGEMENT, LLC 1.6% 438,352 0% $9,655,240
GOLDMAN SACHS GROUP INC 1.3% 344,541 0% $7,586,795
TUDOR INVESTMENT CORP ET AL 0.95% 262,344 0.03% $5,776,815
Peapod Lane Capital LLC 0.77% 210,783 3.5% $4,641,442
BANK OF AMERICA CORP /DE/ 0.69% 190,184 0% $4,187,852
VANGUARD PORTFOLIO MANAGEMENT LLC 0.65% 179,293 0% $3,948,032
Connor, Clark & Lunn Investment Management Ltd. 0.63% 174,331 0.01% $3,838,769
Quantinno Capital Management LP 0.5% 138,486 0% $3,049,462
Jump Financial, LLC 0.48% 132,915 0.02% $2,926,788
CAXTON ASSOCIATES LLP 0.48% 131,066 0.06% $2,886,073
Hennion & Walsh Asset Management, Inc. 0.42% 115,185 0.07% $2,536,374
VANGUARD FIDUCIARY TRUST CO 0.42% 114,439 0% $2,519,947
XTX Topco Ltd 0.34% 93,074 0.03% $2,049,489
PRELUDE CAPITAL MANAGEMENT, LLC 0.24% 66,816 0.11% $1,471,288
ExodusPoint Capital Management, LP 0.24% 65,606 0.01% $1,444,644
Invesco Ltd. 0.23% 64,531 0% $1,420,973
PDT Partners, LLC 0.21% 58,138 0.07% $1,280,199
Point72 Asset Management, L.P. 0.2% 54,318 0% $1,196,082
FEDERATED HERMES, INC. 0.18% 49,766 0% $1,095,847
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 0.16% 44,802 0% $986,540

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
41
Headline period
Q3 2026
Rows shown
1-25 of 41
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 8,256,947 $181,820,594 -$6,046,185 $22.02 86
2026 Q2 15,688,736 $321,831,694 -$28,313,389 $20.52 140
2026 Q1 17,449,202 $277,268,819 -$17,907,084 $15.90 156
2025 Q4 17,853,481 $468,977,899 +$23,698,644 $26.27 180
2025 Q3 17,228,150 $389,319,933 +$21,532,182 $22.60 163
2025 Q2 16,260,263 $323,227,753 +$1,152,439 $19.88 165
2025 Q1 16,317,307 $275,768,406 -$14,217,098 $16.90 173
2024 Q4 17,016,195 $314,285,279 +$12,985,883 $18.47 185
2024 Q3 16,092,056 $349,642,907 +$18,556,959 $21.73 181
2024 Q2 15,271,785 $299,655,107 +$9,367,412 $19.62 170
2024 Q1 14,727,786 $319,564,135 +$6,539,138 $21.70 177
2023 Q4 14,302,809 $413,495,913 +$4,547,542 $28.91 193
2023 Q3 14,229,204 $380,479,266 +$6,537,668 $26.74 196
2023 Q2 13,900,018 $514,629,091 +$13,570,378 $37.03 210
2023 Q1 13,537,003 $422,618,519 +$14,324,645 $31.22 213
2022 Q4 13,130,080 $391,069,830 -$9,588,373 $29.78 218
2022 Q3 13,298,290 $506,859,271 -$7,820,533 $38.12 217
2022 Q2 12,997,411 $708,963,224 +$53,955,153 $54.53 247
2022 Q1 12,047,292 $751,600,750 +$40,161,746 $62.41 263
2021 Q4 11,205,792 $1,127,293,672 -$26,292,784 $100.59 284
2021 Q3 11,367,430 $1,022,253,660 +$64,809,061 $89.95 258
2021 Q2 10,632,791 $980,578,944 +$54,311,867 $92.23 246
2021 Q1 10,008,047 $966,031,706 +$64,885,192 $96.62 243
2020 Q4 9,615,937 $501,565,082 +$82,198,208 $52.10 184
2020 Q3 8,084,326 $323,850,761 +$79,786,110 $40.04 122
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .